Oric Pharmaceuticals Inc (ORIC)
US$ 8.032.42%
Price Chart
Key Statistics
Market Cap
$ 365.39M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
632.33K
52W High
$ 14.67
52W Low
$ 3.90
Dividend Yield
0.00%
Beta
1.36
Technicals
50-Day MA
5.7489
200-Day MA
8.4935
52 Week High
14.67
52 Week Low
3.8951
About ORIC
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.
Employees
122
Headquarters
South San Francisco, CA
CEO
Dr. Richard A. Heyman Ph.D.
Latest News
Outcry as Serbia Demands Handover of Srebrenica's Muslim Commander - Naharnet
Yesterday • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg